October 8, 2024 12:00 PM EDT

Compounding pharmacy group sues FDA for ending Eli Lilly's GLP-1 drug shortage

Shelby Livingston

Senior health tech reporter

A trade group for large compounding pharmacies sued the FDA over its move to take Eli Lilly’s blockbuster GLP-1 drug off its shortage list, hamstringing …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Compounding pharmacy group sues FDA for ending Eli Lilly's GLP-1 drug shortage

Shelby Livingston

Senior health tech reporter

Sign up to read this article for free.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

Pfizer's former top executives pitched changes to board as part of activist's plan

Exclusive: A small San Diego biotech wants to change how Parkinson’s disease is diagnosed

Sage faces third study fail in six months as Alzheimer's candidate misses Phase 2 goal

Exclusive: Tiny startup with big vision to extend healthspan by 20 years says it discovered an ‘Atlas of ...

Astellas places new bet on gene therapy in $50M upfront deal with UK startup

John Maraganore's RNAi biotech City Therapeutics debuts with $135M Series A

Com­pound­ing phar­ma­cy group sues FDA for end­ing Eli Lil­ly's GLP-1 drug short­age

Senior health tech reporter

Sign up to read this article for free.

more like this

Viridian Therapeutics

Waltham, MA, USA

Compounding pharmacy group sues FDA for ending Eli Lilly's GLP-1 drug shortage